EFT adipocytes of CAD patients are characterized by changes in the adipocytokine system: low level of adiponectin gene expression against a high level of leptin gene expression and secretion compared to adipocytes at other locations. This evidence concerns the gene ADIPOQ and coronary artery disorder.